September 16, 2020
ATUM Biotechnology acquired a 40,136-square-foot industrial building in Newark from QQE Properties LLC for nearly $9 million. The buyer, a provider of tools and solutions to life science researchers, plans to expand and relocate its nearby headquarters.
The property at 8484 Central Ave. is a freestanding industrial building located in a business park near the Dumbarton Bridge. Tenant improvements to convert the property into a lab and office space are underway.
The buyer was represented by Colliers International, Avison Young’s Brian Mason, as well as Cushman & Wakefield’s Jeff Powers. Colliers’ Todd Severson, SIOR, represented the seller.
Severson says, “Not only has the industrial market shown incredible resiliency throughout the pandemic, owner occupied buildings are in strong demand.”
For comments, questions or concerns, please contact Dennis Kaiser